Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Nov 29, 2012

Q-Biologicals Enters Animal Health Collaboration

  • Q-Biologicals signed an agreement with Virbac, a French veterinary company. Q-Biologicals will collaborate with Virbac in the development of technologies and production processes suitable for Virbac biological projects in animal health. With this agreement, Virbac prolongs the existing relationship with Q-Biologicals and will be able to use the company’s experience in the production of recombinant proteins, viruses, and microbial live cells.

    “The signing of a five-year framework agreement with one of the leading veterinary companies is a strong recognition of Q-Biologicals’ knowledge and practical experience as contract manufacturing company in the field of biologicals,” says Annie Van Broekhoven, Q-Biologicals’ CEO.

    Q-Biologicals produces recombinant proteins derived from microbial and eukaryotic systems, and conducts purification for research purposes, toxicological studies, and clinical trials, including formulation development and stress stability studies. The company also has experience in the manufacturing of viruses and living cells for vaccine purposes.

    Earlier this year, Q-Biologicals entered a service framework agreement with Bayer CropScience to produce and purify recombinant proteins for Bayer.

Related content


GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Pharmacists and Prescription Drug Misuse Programs

Do you agree that pharmacists should make a greater effort to become more involved with prescription drug-monitoring programs?

More »